The management of pediatric medical emergencies is a focus of WHO's strategy to reduce child and adolescent morbidity and mortality worldwide. It requires the synergy of several inputs including infrastructure, equipment and a sufficiently trained staff. The aim of our study was to present the epidemiological aspects of pediatric medical emergencies at Kindu General Reference Hospital in order to facilitate the projection of the actions to be carried out. To do this, we undertook a cross-sectional, descriptive and retrospective study by collecting the data in the pediatric ward of Kindu General Reference Hospital from January 1st to December 31st, 2017 with age, sex, month of admission, emergency sign, diagnostic hypothesis, treatment, length of stay and discharge modality as study's variables in children with an emergency sign (difficulty breathing, convulsion, coma, shock and severe dehydration). After processing data on Excel 2010 and SPSS 23 software, the analysis by descriptive statistical measures shows that the frequency of signs of medical emergency in children is 21.4% among which 52.3% are male, over 70% of children with emergency signs are under the age of five with an average age of 2.1 years, the high frequency of signs of urgency was observed in June, the decreasing order of frequency of various emergency signs is severe dehydration (58.9%), seizures (24.1%), difficulty breathing (10.3%), coma (5.6%
Sickle cell disease is the most common genetic disorder of hemoglobin in the world today. Screening is the basis of any program aimed at its fight. Faced with the difficulties of implementing screening in countries with limited resources, it is important to resort to alternative strategies, in particular the optimization of clinical suspicion. This study was conducted with the objective of presenting the clinical characteristics of SS sickle cell disease revealed by laboratory screening in pediatric hospitals. A cross-sectional, descriptive study with prospective collection was carried out in 5 health facilities in the city of Kindu in the DRC between December 2, 2019 to October 15, 2020. Our results show that the hospital prevalence of major sickle cell syndrome was 12.7% in the study population. Boys accounted for 53% of cases. The most represented age group was 48 to 59 months with 56.1%. On the clinical level, the examination of our respondents objectified a malnutrition in 36.8% of cases, the presence of frontal bumps in 10.5% of cases, lymphadenopathy in 10.5% of cases, hypertrophy of the tonsils. in 8.8% of cases, conjunctival jaundice in 35.1% of cases, hepatomegaly in 7.0% of cases and splenomegaly in 21.1% of cases. There are significant associations between certain epidemiological characteristics studied in homozygous SS subjects, in particular the age of 48 to 59 months with jaundice (p = 0.012) and splenomegaly (p = 0.028), undernutrition with jaundice (p = 0.037) and the presence of lymphadenopathy (p = 0.013), presence of frontal lumps with enlarged tonsils (p = 0.0001) and hepatomegaly (p = 0.008), splenomegaly with jaundice (p = 0.001) and presence of lymphadenopathy (p = 0.004) and finally hepatomegaly and the presence of lymphadenopathy (p = 0.008). In short, it emerges that many children with major sickle cell syndrome have a less expressive clinical presentation. This is probably linked to the fact that at this age they still have a level of hemoglobin F sufficient to attenuate the impact of hemoglobin S. The associations observed between various clinical parameters show that it is possible to develop a clinic score that can guide the suspicion of the disease and motivate a biological screening.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.